Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Terrain Minerals

    MCap

    AUD12m

    Last close

    AUD0.00

    ▲ 0.00 (33.33%)

    Ajax Resources

    MCap

    GBP7m

    Last close

    GBP0.06

    ▲ 0.50 (8.70%)

    Cadence Minerals

    MCap

    GBP25m

    Last close

    GBP0.06

    ▲ 0.45 (7.96%)

  • Sectors

    Sectors

  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Cereno Scientific – executive interview

Cereno Scientific – executive interview

Cereno Scientific — 12 videos in collection

More on this equity

In this interview, we speak with Sten Sörensen, CEO of Cereno Scientific, about the company’s strong start to 2026 and the key takeaways from the Q126 results. He provides updates on CS1 ahead of its planned Phase IIb trial in pulmonary arterial hypertension (PAH), discusses the advancement of CS014 in PH associated with interstitial lung disease (PH-ILD) and the ongoing pharmacokinetic bridging study, and explains the rationale for selecting antiphospholipid syndrome (APS) as the lead indication for CS585. Sten also highlights how the company’s clinical programmes are aligned with the evolving regulatory landscape, helping to de-risk development, and comments on growing interest from potential pharmaceutical partners. He concludes by outlining the key milestones and catalysts investors can expect over the coming months, setting the stage for a newsflow-rich period.

< Previous
Next >

You may also be interested in these:

Healthcare

Cereno Scientific – executive interview

Healthcare

Cereno Scientific – Leadership perspectives from the capital markets day
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.